Australian University Rankings Guide

Value in Health Regional Issues (ERA Journal)

Value in Health Regional Issues is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Value in Health Regional Issues issns are issn1: 2212-1099 issn2: 2212-1102.

The fields covered by Value in Health Regional Issues as part of the evaluation of Australian university research excellence are:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Public Health and Health Services Research Rankings (Sub-Field)

Applied Economics Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- Angiogenesis
- Anti-Cancer Drugs: international journal on anti-cancer agents
- Antiviral Research
- Asian Journal of Pharmaceutical Sciences
- Environmental Toxicology and Pharmacology
- Expert Review of Clinical Pharmacology
- Formulary: a peer-reviewed drug management journal for managed care and hospital decision makers
- Infectious diseases and therapy
- International Journal of Immunopathology and Pharmacology
- Journal of Pharmaceutical Health Services Research
- Journal of Pharmacological and Toxicological Methods
- Lettre du Pharmacologue
- Pharmaceutical Patent Analyst
- Pharmacological Research
- Therapeutic Advances in Endocrinology and Metabolism


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4